Skip to main content
Premium Trial:

Request an Annual Quote

Mitochondrial Dysfunction Implicated in Glaucoma

Researchers from India and the UK found pathogenic mitochondrial DNA mutations in half of the primary open-angle glaucoma patients they sequenced, as they report in Genetics in Medicine.

The University of Liverpool's Colin Willoughby and his colleagues sequenced the whole mitochondrial genomes of 32 patients with primary open-angle glaucoma, half from India and half from Ireland. Sixteen patients, they found, had 22 mitochondrial DNA mutations, including seven novel mutations and eight that had previously been linked to disease. Additionally, eight of the 22 mutations affected complex I mitochondrial genes

This suggests to Willoughby and his team that mitochondrial dysfunction and complex I are involved in the development of primary open-angle glaucoma.

"Understanding the genetic basis of glaucoma can direct care by helping to determine the patient's clinical risk of disease progression and visual loss," he says in a statement. "Increasing evidence suggests that mitochondrial dysfunction results in glaucoma and drugs that target mitochondria may emerge as future therapeutic interventions."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.